Ontology highlight
ABSTRACT: Introduction
Ketamine has received attention recently as an agent for chronic pain. There are concerns, however, regarding the neurocognitive changes patients might experience after ketamine exposure.Methods
This prospective, uncontrolled study describes the neurocognitive functioning of 11 children with chronic pain before and after 2 weeks of daily oral ketamine exposure. Neurocognitive assessment was performed at baseline, Week 2, and Week 14. We hypothesized that there would be declines in neurocognitive scores at either Week 2 or Week 14.Results
No decline in neurocognitive function was detected in the children investigated. Mean scores for tests measuring executive function and memory were improved at Weeks 2 and 14 compared to baseline.Discussion
This
SUBMITTER: Bredlau AL
PROVIDER: S-EPMC4618408 | biostudies-literature | 2015 Mar
REPOSITORIES: biostudies-literature